SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-043166
Filing Date
2021-02-16
Accepted
2021-02-16 06:18:58
Documents
2
Group Members
CORRIENTE MASTER FUND II, LPMARK L. HART III

Document Format Files

Seq Description Document Type Size
1 SC 13G d100462dsc13g.htm SC 13G 77584
2 EX-99.A d100462dex99a.htm EX-99.A 3497
  Complete submission text file 0001193125-21-043166.txt   82911
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Subject) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80378 | Film No.: 21631972
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107
Business Address 1401 FOCH ST SUITE 100 FORT WORTH TX 76107 8178700400
Corriente Advisors, LLC (Filed by) CIK: 0001406718 (see all company filings)

IRS No.: 752939516 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G